Jeff Knox
Investor at Innospark Ventures
Jeff Knox
Investor at Innospark Ventures
Boston, Massachusetts
Overview
Work Experience
Investor
2022 - Current
Innospark is an early-stage venture capital firm supporting founders who put data science and AI to work solving hard problems in life sciences, healthcare, and vertical enterprise.
Co-Managing Director, Boston
2021 - 2022
Lead, Operations
2020 - 2021
Nucleate Bio is an entrepreneurship organization enabling the formation of life science ventures. The Boston-born initiative counts more than 100 alumni teams that have gone on to raise more than $300M in outside funding, and operates in cities across the US and around the world.
Business Development
2021 - 2022
Carmine is a biotechnology company developing novel non-viral gene therapies leveraging the properties of red blood cell extracellular vesicles.
Business Development Intern, Center for External Innovation
2021 - 2021
The Center for External Innovation sources, transacts and supports external ideas for creating new therapeutic options in Takeda’s areas of focus. The CEI oversees all R&D business development, venture investments, academic alliances, and externalizations, and supports M&A efforts as well.
MBA Intern, Binney Street Capital, Venture Capital
2021 - 2021
Binney Street Capital is Dana-Farber’s first-ever venture fund, capitalizing on investment opportunities created by Dana-Farber innovations and investigators.
MBA Intern
2021 - 2021
Lifespan Equity Partners is a private equity firm that invests in healthcare service and technology businesses that improve quality of care.
Associate Principal
2020 - 2020
Engagement Manager
2018 - 2020
Senior Consultant
2016 - 2018
Consultant
2015 - 2016
Associate Consultant
2014 - 2015
Trinity is a life sciences consultancy integrating research, analytics, and technology to better advise the commercialization of new interventions improving human health.